← Foresight Institute Fellowship 2027 HIGH Neuropharm/CCT
AI Draft — Foresight Institute Fellowship 2027
Foresight Institute
Eniola's strongest angle is GATE-first, CCT-as-substrate: lead the application by positioning GATE (open-source BCI neural-stimulation safety evaluation platform, Apache 2.0) as a direct contribution to Foresight's Neurotechnology mission using the program's own verbatim language — 'brain-computer interfaces' and 'neuro-informed AI' — then establish that GATE is scientifically grounded because it rests on a fully specified pharmacological theory (CCT) validated computationally (ODE/RK45 + Bayesian MCMC, 85.8% encoding probability reduction, H1–H5 confirmed) and documented in three sole-authored preprints with endorsement from Harvard (Gershman), Princeton (Daw), Michigan (Berridge), and NYU (Mattar). The narrative arc is full-stack and structurally unusual: independent researcher in Lagos, no institutional lab, no PhD — yet she built a coherent pharmacological framework, proved it computationally, converted it into open-source BCI safety tooling, filed a provisional patent, and assembled an advisory constellation that reads like a top-10 computational neuroscience program. Foresight explicitly prizes moonshots; Eniola's independence is a feature to foreground, not a liability to defend — she is simultaneously the PI, the engineer, and the builder, exactly the scientist+builder archetype that defines the fellowship's most celebrated fellows. TOPOLOGIX (TDA for drug-protein interaction, persistent homology) provides a secondary hook on the Nanotechnology track's 'molecular simulation and modeling software' language if form fields allow.
Full Research →
Model: pardalos/auto
Tokens: 0
Generated: 2026-07-09 17:16
Profile: researcher
The complete application materials are saved to: /tmp/pardalosoutput/545f0f972d/foresightfellowship2027application.txt Here is what the document contains and the key decisions made in drafting it: MOTIVATION STATEMENT (~400 words) Opens with the structural problem, BCI devices regulated as devices, not as pharmacological interventions, rather than with self-introduction. Uses Foresight's exact verbatim track language ("brain-computer interfaces," "neuro-informed AI") to make the alignment explicit. Leads with GATE as the primary vehicle, then grounds it in CCT. All five confirmed hypotheses, the 85.8% encoding probability reduction, and the +12.8 pp super-additivity figure appear by name. Ends with a specific ask tied to the fellowship's stated deliverables (workshops, seminar group, Vision Weekend network). PROJECT DESCRIPTION (~500 words) Structured as a technical document, not a pitch. Opens with the gap GATE fills (pharmacological evaluation of neural stimulation), presents the ODE system and threshold condition in plain text notation, walks through the Bayesian inference pipeline, and states current implementation status per module. The roadmap section is honest about what is complete versus in progress. Closes by naming exactly how Foresight's resources accelerate the specific next phase (adverse-event dataset calibration). TECHNICAL WORK SAMPLE Describes each of the three preprints as a standalone document with its DOI and what it contributes to the GATE scientific foundation. Also flags the TOPOLOGIX TDA exhibit as a supplementary option if reviewers want the hERG module methodology. EDITOR NOTES flags five things that need Eniola's attention before submission: 1. Visa and travel logistics for international applicants 2. GATE repository must be public with a usable README before submission 3. The Alcohol (Elsevier) paper status should be updated if accepted before the deadline 4. Form field mapping guidance, since the live form fields are not visible from the public page 5. Nomination route: if Foresight's form allows a nominator, one short letter from Gershman or Daw naming GATE specifically is worth pursuing before July 21